Diagnosis of<unk>  is separated into primary and secondary presentation. There is no single test to confirm a diagnosis of either form of<unk> . It is instead a diagnosis made after a thorough clinical history, documentation of common symptoms, clinical evaluation, and exclusion of all other possible conditions. The diagnosis of primary<unk>  is made upon blood tests to confirm not only hemolytic anemia and immune thrombocytopenic purpura, but also a positive direct antiglobulin test (DAT) and an absence of any known underlying cause. Additional tests used to eliminate the possibility of other conditions include a computed tomography (CT) scan and a biopsy of bone marrow. A diagnosis of secondary<unk>  is indicative of occurrence after another autoimmune disease is already present. In 27% to 50% of cases there is an associated malignancy or a predisposing autoimmune disease. Pre-existing autoimmune diseases can include autoimmune lymphoproliferative syndrome (ALPS), combined variable immunodeficiency (CVID), systemic autoimmune disease, or another disorder of immune dysregulation. Other antibodies may occur directed against neutrophils and lymphocytes, and "immunopancytopenia" has been suggested as an alternative term for this syndrome.
Evans syndrome
Zaki syndrome
Walker–Warburg syndrome
Morvan's syndrome
Rabbit syndrome
Michels Caskey syndrome
Antley–Bixler syndrome
Branchio-oto-renal syndrome